(Q43503382)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2095347%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

title

Stereoselectivity of cholinesterase inhibition by galanthamine and tolerance in humans (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2095347%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference

cholinesterase inhibition

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2095347%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

author name string

T Thomsen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2095347%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

J P Fischer

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2095347%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

H Kewitz

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2095347%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

publication date

1 January 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2095347%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

10 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2095347%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2095347%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2095347%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

page(s)

603-605

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2095347%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00316106

10 October 2019

exact match

0 references

cites work

The interaction of human cholinesterases with anticholinesterases used in the therapy of myasthenia gravis

1 reference

12 December 2020

Pharmacokinetics of galanthamine hydrobromide after single subcutaneous and oral dosage in humans

1 reference

12 December 2020

On the molecular mechanism of action of galanthamine, an antagonist of nondepolarizing muscle relaxants (author's transl)

1 reference

12 December 2020

Selective inhibition of human acetylcholinesterase by galanthamine in vitro and in vivo.

1 reference

12 December 2020

Reversed-phase liquid chromatography for the determination of galanthamine and its metabolites in human plasma and urine

1 reference

12 December 2020

A suitable method to monitor inhibition of cholinesterase activities in tissues as induced by reversible enzyme inhibitors

1 reference

12 December 2020

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

12 December 2020

Estimation of cholinesterase activity (EC 3.1.1.7; 3.1.1.8) in undiluted plasma and erythrocytes as a tool for measuring in vivo effects of reversible inhibitors

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00316106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2095347%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference